Three-year follow-up of oral BG-12 (dimethyl fumarate) treatment in relapsing remitting multiple sclerosis (RRMS): integrated magnetic resonance imaging (MRI) outcomes from DEFINE, CONFIRM, and ENDORSE

被引：0
|
作者：
Miller, D. H. [1 ]
Fox, R. J. [2 ]
Gold, R. [3 ]
Havrdova, E. [4 ]
Kappos, L. [5 ]
MacManus, D. [1 ]
Yousry, T. [1 ]
Zhang, R.
Yang, M.
Viglietta, V.
Sheikh, S. I.
Dawson, K. T.
Arnold, D. L. [6 ,7 ]
机构：
[1] UCL, Inst Neurol, Queens Sq MS Ctr, London, England
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[3] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[4] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[5] Univ Basel Hosp, Basel Neurol, CH-4031 Basel, Switzerland
[6] NeuroRx Res, Montreal, PQ, Canada
[7] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [1] Three-year follow-up of oral BG-12 (dimethyl fumarate) treatment in relapsing remitting multiple sclerosis (RRMS): integrated clinical efficacy data from the DEFINE, CONFIRM, and ENDORSE studies
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 222 - 222
  • [2] 3-Year Follow-up of Oral BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Clinical Outcomes from the DEFINE, CONFIRM, and ENDORSE Studies
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Rana, J.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 932 - 932
  • [3] Effects of oral BG-12 (Dimethyl Fumarate) on Magnetic Resonance Imaging (Mri) Outcomes in Relapsing-Remitting Multiple Sclerosis (Rrms): an Integrated Analysis of the Phase 3 Define and Confirm Studies
    Bar-Or, A.
    Arnold, D. L.
    Gold, R.
    Fox, R. J.
    MacManus, D. G.
    Yousry, T.
    Kurukulasuriya, N. C.
    Zhang, R.
    Viglietta, V.
    Stephan, M.
    Dawson, K. T.
    Miller, D. H.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1836 - 1836
  • [4] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
  • [5] Efficacy of Oral BG-12 (Dimethyl Fumarate) in Patients Newly Diagnosed with Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Analysis of DEFINE and CONFIRM
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Rana, J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 931 - 932
  • [6] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated MRI outcomes from DEFINE, CONFIRM, and the ENDORSE extension study
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D. G.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Miller, D. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 130 - 130
  • [7] 4-year follow-up of delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis (RRMS): integrated MRI outcomes from DEFINE, CONFIRM, and the ENDORSE extension study
    Arnold, D. L.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Yousry, T.
    MacManus, D. G.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Miller, D. H.
    JOURNAL OF NEUROLOGY, 2014, 261 : S93 - S93
  • [8] Effect of BG-12 (dimethyl fumarate) in newly diagnosed relapsing remitting multiple sclerosis (RRMS) patients from the DEFINE and CONFIRM studies
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Zhang, A.
    Meltzer, L.
    Kurukulasuriya, N. C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 453 - 454
  • [9] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral BG-12 (Dimethyl Fumarate) in DEFINE and CONFIRM
    Meltzer, Leslie
    Selmaj, Krzysztof
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Pace, Amy
    Novas, Mark
    Hotermans, Christophe
    Dawson, Katherine
    Phillips, J. Theodore
    NEUROLOGY, 2013, 80
  • [10] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral Bg-12 (Dimethyl Fumarate) in Define and Confirm
    Bar-Or, A.
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Kurukulasuriya, N. C.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1840 - 1841
12345